Anubhab Mukherjee

2.6k total citations · 2 hit papers
18 papers, 1.8k citations indexed

About

Anubhab Mukherjee is a scholar working on Biomedical Engineering, Molecular Biology and Biomaterials. According to data from OpenAlex, Anubhab Mukherjee has authored 18 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Biomedical Engineering, 7 papers in Molecular Biology and 7 papers in Biomaterials. Recurrent topics in Anubhab Mukherjee's work include Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (7 papers) and RNA Interference and Gene Delivery (3 papers). Anubhab Mukherjee is often cited by papers focused on Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (7 papers) and RNA Interference and Gene Delivery (3 papers). Anubhab Mukherjee collaborates with scholars based in United States, India and Norway. Anubhab Mukherjee's co-authors include Manash K. Paul, Sudip Mukherjee, Bharti Bisht, Vijay Sagar Madamsetty, Purvish M. Parikh, Pravin D. Potdar, Navneet Singh, Aritraa Lahiri, Santosh Kesari and Venkata Mahidhar Yenugonda and has published in prestigious journals such as Advanced Materials, Advanced Functional Materials and International Journal of Molecular Sciences.

In The Last Decade

Anubhab Mukherjee

16 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lung cancer immunotherapy: progress, pitfalls, and promises

2023 568 citations Aritraa Lahiri, Pravin D. Potdar et al. Molecular Cancer profile →
<p>Lipid–polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives</p>

2019 357 citations Anubhab Mukherjee, Achal S. Achrol et al. International Journal of Nanomedicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anubhab Mukherjee United States	12	688	609	450	371	283	18	1.8k
Jooho Park South Korea	26	920 1.3×	760 1.2×	622 1.4×	404 1.1×	199 0.7×	73	2.1k
Alan Chan Netherlands	27	743 1.1×	725 1.2×	292 0.6×	245 0.7×	290 1.0×	73	2.1k
Yanyan Jiang China	26	1.0k 1.5×	687 1.1×	733 1.6×	284 0.8×	146 0.5×	50	2.2k
Edgar Pérez‐Herrero Spain	16	707 1.0×	760 1.2×	771 1.7×	252 0.7×	124 0.4×	21	1.9k
Shuang Cai China	23	815 1.2×	335 0.6×	370 0.8×	309 0.8×	248 0.9×	60	1.8k
Fan Tong China	22	501 0.7×	884 1.5×	511 1.1×	235 0.6×	188 0.7×	50	1.5k
Bo Lü China	24	862 1.3×	532 0.9×	746 1.7×	331 0.9×	148 0.5×	74	2.1k
Tianze Jiang China	22	612 0.9×	1.1k 1.7×	723 1.6×	263 0.7×	156 0.6×	38	2.0k
Meng Zhou China	20	890 1.3×	349 0.6×	450 1.0×	261 0.7×	115 0.4×	46	1.9k
Ann L.B. Seynhaeve Netherlands	27	879 1.3×	867 1.4×	846 1.9×	405 1.1×	221 0.8×	64	2.1k

Countries citing papers authored by Anubhab Mukherjee

Since Specialization

Citations

This map shows the geographic impact of Anubhab Mukherjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anubhab Mukherjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anubhab Mukherjee more than expected).

Fields of papers citing papers by Anubhab Mukherjee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anubhab Mukherjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anubhab Mukherjee. The network helps show where Anubhab Mukherjee may publish in the future.

Co-authorship network of co-authors of Anubhab Mukherjee

This figure shows the co-authorship network connecting the top 25 collaborators of Anubhab Mukherjee. A scholar is included among the top collaborators of Anubhab Mukherjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anubhab Mukherjee. Anubhab Mukherjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Mukherjee, Anubhab & Hemant B. Kaushik. (2024). Strengthening of unreinforced masonry buildings with ferrocement composite overlay: Material characterization and numerical study. Case Studies in Construction Materials. 22. e04177–e04177. 4 indexed citations

Mukherjee, Anubhab, et al.. (2024). Quality by Design (QbD) Aided Formulation Optimization of Amlodipine Besylate Oral Thin Film. Indian Journal of Pharmaceutical Education and Research. 58(2s). s444–s452. 1 indexed citations

Lahiri, Aritraa, Pravin D. Potdar, Navneet Singh, et al.. (2023). Lung cancer immunotherapy: progress, pitfalls, and promises. Molecular Cancer. 22(1). 40–40. 568 indexed citations breakdown →

Mukherjee, Anubhab & Hemant B. Kaushik. (2023). Numerical assessment of role of ferrocement overlay in strengthening of unreinforced masonry walls. Materials Today Proceedings. 2 indexed citations

Bhattacharya, Dwaipayan, et al.. (2022). Communication in non-communicable diseases (NCDs) and role of immunomodulatory nutraceuticals in their management. Frontiers in Nutrition. 9. 966152–966152. 5 indexed citations

Mukherjee, Anubhab, Bharti Bisht, Suman Dutta, & Manash K. Paul. (2022). Current advances in the use of exosomes, liposomes, and bioengineered hybrid nanovesicles in cancer detection and therapy. Acta Pharmacologica Sinica. 43(11). 2759–2776. 102 indexed citations

Mukherjee, Anubhab, et al.. (2022). Managing Cachexia and Improving Quality of Life in Cancer Patients Using Novel Nutritional Supplements: A PAN India Study. Journal of Cancer Therapy. 13(2). 88–104.

Bisht, Bharti, et al.. (2021). Advances in the Fabrication of Scaffold and 3D Printing of Biomimetic Bone Graft. Annals of Biomedical Engineering. 49(4). 1128–1150. 68 indexed citations

Mukherjee, Anubhab, Vijay Sagar Madamsetty, & Sudip Mukherjee. (2021). Emerging Trends in Immunomodulatory Nanomaterials Toward Cancer Therapy. 3 indexed citations

10.

Mukherjee, Sudip, Vijay Sagar Madamsetty, Dwaipayan Bhattacharya, et al.. (2020). Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics. Advanced Functional Materials. 30(35). 110 indexed citations

11.

Mukherjee, Anubhab, Vijay Sagar Madamsetty, Manash K. Paul, & Sudip Mukherjee. (2020). Recent Advancements of Nanomedicine towards Antiangiogenic Therapy in Cancer. International Journal of Molecular Sciences. 21(2). 455–455. 66 indexed citations

12.

Ovais, Muhammad, Sudip Mukherjee, A. Pramanik, et al.. (2020). Designing Stimuli‐Responsive Upconversion Nanoparticles that Exploit the Tumor Microenvironment. Advanced Materials. 32(22). e2000055–e2000055. 177 indexed citations

13.

Madamsetty, Vijay Sagar, Manash K. Paul, Anubhab Mukherjee, & Sudip Mukherjee. (2019). Functionalization of Nanomaterials and Their Application in Melanoma Cancer Theranostics. ACS Biomaterials Science & Engineering. 6(1). 167–181. 33 indexed citations

14.

Madamsetty, Vijay Sagar, Anubhab Mukherjee, & Sudip Mukherjee. (2019). Recent Trends of the Bio-Inspired Nanoparticles in Cancer Theranostics. Frontiers in Pharmacology. 10. 1264–1264. 142 indexed citations

15.

Mukherjee, Anubhab, Manash K. Paul, & Sudip Mukherjee. (2019). Recent Progress in the Theranostics Application of Nanomedicine in Lung Cancer. Cancers. 11(5). 597–597. 86 indexed citations

16.

Mukherjee, Anubhab, et al.. (2019). <p>Lipid–polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives</p>. International Journal of Nanomedicine. Volume 14. 1937–1952. 357 indexed citations breakdown →

17.

Mukherjee, Anubhab, Ivan Babić, Elmar Nurmemmedov, et al.. (2018). Antibody drug conjugates: Progress, pitfalls, and promises. Human Antibodies. 27(1). 53–62. 23 indexed citations

18.

Mukherjee, Anubhab, Jayanta Bhattacharyya, Vijay Sagar Madamsetty, & Arabinda Chaudhuri. (2013). Liposomally encapsulated CDC20 siRNA inhibits both solid melanoma tumor growth and spontaneous growth of intravenously injected melanoma cells on mouse lung. Drug Delivery and Translational Research. 3(3). 224–234. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact